Director of the Board
Ms. Keren Haruvi is President of Sandoz US and Head of North America. In this role, she leads Sandoz’ largest commercial and country organization – the United States – which is responsible for over 35% of Sandoz global revenue. She also oversees Sandoz commercial operations in Canada. In addition to serving on the Novartis Country Leadership Team, Keren is a member of the Global Sandoz Executive Committee.
Prior to joining Sandoz, Keren served as Global Head of M&A at Novartis International AG. Her early career began at Teva Pharmaceutical Industries where she steadily advanced in leadership roles to Senior VP, Global Business Development and Alliance Management. Over the years, she demonstrated her prowess in knowing when to walk away and when to drive deals from identification through execution to closing, integration, and rationalization.
Keren is a value creator in the biopharmaceutical space. She brings 17 years of experience in the pharmaceutical industry marked by success leading major M&A deals, enterprise innovations, and complex market strategies for large-scale, sustainable growth. She is known as an authentic, empathetic, and inspirational champion of teams with an unparalleled appreciation and vision for what can be accomplished when diverse stakeholders are mobilized around common goals and objectives.
Keren holds an MBA in Finance from Bar Ilan University and a Bachelor’s degrees in Economics and Chemistry from Tel Aviv University. Nominated for Top 40 Under 40 in The Marker magazine, she exemplifies the insight and wisdom needed to move global organizations forward. Outside of work, Keren enjoys spending time with her 5 children. She is an avid runner with one marathon and 3 half-marathons under her belt.